ScreenerHero
TMOThermo Fisher Scientific Inc.
NYSE · US · Healthcare · Diagnostics & Research · thermofisher.com
568.26USD-0.71%Mkt Cap: 211.18B $P/E: 30.55

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Scien…

Industry Peers

Diagnostics & Research
Screen all
DHR
Danaher Corporation
$134.62BUSDP/E 34.2
LONN
Lonza Group Ltd
$43.68BUSDP/E 35.3
IDXX
IDEXX Laboratories, Inc.
$42.94BUSDP/E 40.1
A
Agilent Technologies, Inc.
$39.14BUSDP/E 27.9
NTRA
Natera, Inc.
$37.52BUSD
WAT
Waters Corporation
$36.79BUSDP/E 47.5
IQV
IQVIA Holdings Inc
$34.72BUSDP/E 25.9
ILMN
Illumina, Inc.
$29.37BUSDP/E 35.4
MTD
Mettler-Toledo International, Inc.
$26.82BUSDP/E 31.1
DGX
Quest Diagnostics Incorporated
$25.06BUSDP/E 24.2
LH
Laboratory Corporation of America Holdings
$24.34BUSDP/E 26.3
GH
Guardant Health, Inc.
$19.54BUSD
MEDP
Medpace Holdings, Inc.
$16.78BUSDP/E 35.3
ERF
Eurofins Scientific SE
$12.47BUSDP/E 26.0
RVTY
Revvity Inc. Common Stock
$12.32BUSDP/E 53.1
CRL
Charles River Laboratories International, Inc.
$10.91BUSD
BIM
bioMerieux S.A.
$8.95BUSDP/E 20.9
BLLN
BillionToOne Inc. Class A Common Stock
$5.80BUSDP/E 233.5
TWST
Twist Bioscience Corp.
$5.62BUSD
SHC
Sotera Health Company
$4.95BUSDP/E 42.3
RDNT
RadNet, Inc.
$4.84BUSD
VCYT
Veracyte, Inc.
$4.52BUSDP/E 52.4
DIA
DiaSorin S.p.A.
$3.59BUSDP/E 25.4
ADPT
Adaptive Biotechnologies Corp.
$3.56BUSD
GRAL
GRAIL Inc. Common Stock
$2.91BUSD
CDNA
CareDx, Inc.
$1.92BUSD
VIMIAN
Vimian Group AB (publ)
$1.70BUSDP/E 43.3
NEO
NeoGenomics, Inc.
$1.81BUSD
WGS
GeneDx Holdings Corp. Class A Common Stock
$1.75BUSD
DIA
Diagnostyka S.A.
$1.40BUSDP/E 21.2
PSNL
Personalis, Inc.
$1.26BUSD
CBAV
Clinica Baviera, S.A.
$996.45MUSDP/E 20.9
OPK
OPKO Health, Inc.
$921.21MUSD
CSTL
Castle Biosciences, Inc.
$748.69MUSD
LBIRD
Lumibird SA
$653.57MUSDP/E 42.6
FLGT
Fulgent Genetics, Inc.
$558.64MUSD
MYGN
Myriad Genetics, Inc.
$529.85MUSD
VOX
Voxel S.A.
$318.66MUSDP/E 3.2
EDT
Spectral Medical Inc.
$288.48MUSD
BDSX
Biodesix, Inc.
$227.83MUSD
IMDX
Insight Molecular Diagnostics Inc. Common Stock
$153.06MUSD
SLV
Selvita S.A.
$116.19MUSD
FONR
FONAR Corporation
$120.20MUSDP/E 19.1
XGN
Exagen, Inc.
$113.07MUSD
SCP
Scope Fluidics S.A.
$95.97MUSD
ALECR
Eurofins-Cerep SA
$89.37MUSDP/E 17.2
BIOPOR
BioPorto A/S
$84.73MUSD
PANG
Pangaea Oncology, S.A.
$60.51MUSD
PRPO
Precipio, Inc.
$42.32MUSD
ABDX
Abingdon Health Plc
$31.40MUSD
NN6
NanoRepro AG
$28.79MUSD
GDR
genedrive plc
$21.62MUSD
SENZA
SenzaGen AB
$16.48MUSD
IMMNOV
Immunovia AB
$11.26MUSD
BMX
BioMaxima S.A.
$10.77MUSD
VRCI
Verici Dx plc
$10.27MUSD
XWEL
XWELL Inc. Common Stock
$8.87MUSD
PRM
Proteome Sciences plc
$8.10MUSD
OBD
Oxford BioDynamics Plc
$6.88MUSD
NDRA
ENDRA Life Sciences Inc.
$6.17MUSD
AVCR
Avricore Health Inc.
$4.60MUSD
JUMP
Leveljump Healthcare Corp.
$4.44MUSD
ALPRE
Predilife S.A.
$4.07MUSD
BIAF
bioAffinity Technologies Inc. Common Stock
$4.15MUSD
TELO
Telo Genomics Corp.
$2.93MUSD
ISPC
iSpecimen Inc. Common Stock
$2.83MUSD
NOTV
Inotiv, Inc.
$2.79MUSD
PROGEN
Prostatype Genomics AB (publ)
$2.40MUSD
PRPH
ProPhase Labs, Inc.
$821.3KUSD
MBI-H
Med BioGene Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$5.6KUSD
Indicators:|

Key Statistics

Company
Market Cap211.18B $
Enterprise Value249.43B $
Revenue (TTM)46.34B $
Gross Profit18.24B $
Net Income (TTM)6.70B $
Revenue/Share123.89 USD
Last Price568.26 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees125.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS8835561023
Valuation
P/E (Trailing)30.55
P/E (Forward)20.70
PEG1.87
EV/EBITDA21.25
EV/Revenue5.38
P/S4.56
P/B4.07
EPS (TTM)18.58
EPS (Forward)27.45
52W Range
435.2764% of range643.99
52W High643.99 USD
52W Low435.27 USD
Profitability
Gross Margin40.93%
Oper. Margin18.75%
EBITDA Margin25.33%
Profit Margin15.05%
ROE12.55%
ROA6.08%
Growth
Revenue Growth10.50%
Earnings Growth9.40%
Cash Flow & Leverage
Operating CF7.82B $
CapEx (TTM)1.52B $
FCF Margin13.44%
FCF Yield2.95%
Net Debt38.48B $
Net Debt/EBITDA3.28
Balance Sheet
Debt/Equity0.74
Current Ratio1.55
Quick Ratio0.90
Book Value/Sh139.75 USD
Cash/Share10.95 USD
Dividends
Fwd Div Rate1.880 USD
Trail. Div Rate0.8600 USD
Div. Yield0.33%
5Y Avg Yield0.26%
Payout Ratio9.69%
Ex-Div DateSep 15, 2026
Pay DateOct 15, 2026
Splits
Last Split3:2
Split DateJun 6, 1996
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)618.00 USD
Upside (mean)+8.8%
Target Range510.00 USD – 750.00 USD
$510.00+8.8% to mean$750.00
# Analysts26
Ownership
Shares Out.371.62M
Float370.05M
Insiders0.15%
Institutions93.89%
Short Interest
Short Ratio2.5d
Short % Float1.43%
Short % Out.1.43%
Shares Short5.30M
Short (prev mo.)4.42M
Technical
SMA 50491.99 (+15.5%)
SMA 200529.70 (+7.3%)
Beta0.87
S&P 52W Chg16.00%
Avg Vol (30d)1.69M
Avg Vol (10d)2.50M
Technical Indicators
RSI (14)70.8
MACD16.8228
MACD Signal14.1876
MACD Hist.+2.6352
BB Upper563.16 USD
BB Middle527.20 USD
BB Lower491.23 USD
BB Width13.64%
ATR (14)17.67 USD
Vol Ratio (20d)1.34x